9 months ago
ONC
AnalystsJessica FyeJessica Fye's Stock Forecasts
AnalystsJessica Fye
Analyst Ranking
Top 5%
#234 out of 5315 analysts
Average Return
+20.15%
Win Rate
63%94 out of 149
Risk vs Reward
Poor
Good
Jessica Fye's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Rayzebio IncRYZB | +212.45% | $20.00 | $62.49 | 2023-10-10 - 2024-02-23 | Strong Buy |
Insmed IncINSM | +199.43% | $24.62 | $73.72 | 2023-11-20 - 2024-11-19 | Strong Buy |
Stemline Therapeutics IncSTML | +178.35% | $4.25 | $11.83 | 2020-03-26 - 2020-06-10 | Strong Buy |
Insmed IncINSM | +171.72% | $73.15 | $198.76 | 2024-11-22 - 2025-11-21 | Strong Buy |
Crinetics Pharmaceuticals IncCRNX | +137.44% | $35.18 | $83.53 | 2025-09-24 - 2026-07-07 | Strong Buy |
Jessica Fye Analyst Color
Get additional color on Jessica Fye's coverage of popular stocks
9 months ago
IONS
10 months ago
MIRM
10 months ago
LEGN
a year ago
INSM
a year ago
ASND
a year ago
ALNY
a year ago
ONC
a year ago
ALNY
a year ago
INSM
a year ago
ALNY
a year ago
ASND
a year ago
ALNY
a year ago
ASND
a year ago
INSM
a year ago
ASND
2 years ago
INSM
2 years ago
ITCI
2 years ago
ONC
2 years ago
BMRN
2 years ago
ASND
2 years ago
ONC
2 years ago
JAZZ
2 years ago
DNLI
2 years ago
INSM
Jessica Fye's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mirum Pharmaceuticals IncMIRM | 5 | Strong Buy | $125.00 | -2.58% | Maintains | 6 days ago |
Insmed IncINSM | 10 | Strong Buy | $179.00 | +58.63% | Maintains | a month ago |
Aktis Oncology IncAKTS | 1 | Strong Buy | $30.00 | +8.77% | Initiates Coverage On | 5 months ago |
Denali Therapeutics IncDNLI | 6 | Strong Buy | $26.00 | -1.18% | Maintains | 8 months ago |
Stoke Therapeutics IncSTOK | 3 | Hold | $25.00 | -24.29% | Maintains | 8 months ago |
Novocure LtdNVCR | 5 | Hold | $23.00 | +29.80% | Maintains | 8 months ago |
Jazz Pharmaceuticals PLCJAZZ | 5 | Strong Buy | $199.00 | -19.67% | Maintains | 8 months ago |
Halozyme Therapeutics IncHALO | 9 | Hold | $65.00 | -20.31% | Maintains | 8 months ago |
Moderna IncMRNA | 14 | Strong Sell | $25.00 | -68.66% | Maintains | 8 months ago |
Biontech SeBNTX | 14 | Hold | $120.00 | +27.27% | Maintains | 8 months ago |
Alnylam Pharmaceuticals IncALNY | 9 | Strong Buy | $473.00 | +47.08% | Maintains | 9 months ago |
Legend Biotech CorpLEGN | 4 | Strong Buy | $76.00 | +174.57% | Maintains | 9 months ago |
Incyte CorpINCY | 9 | Hold | $89.00 | -24.61% | Maintains | 9 months ago |
Biomarin Pharmaceutical IncBMRN | 5 | Strong Buy | $119.00 | +97.18% | Maintains | 9 months ago |
Ascendis Pharma AASND | 15 | Strong Buy | $264.00 | -1.11% | Maintains | 9 months ago |
Vertex Pharmaceuticals IncVRTX | 10 | Strong Buy | $530.00 | +1.48% | Maintains | 9 months ago |
Beone Medicines LtdONC | 8 | Strong Buy | $385.00 | +24.61% | Maintains | 9 months ago |
Ionis Pharmaceuticals IncIONS | 7 | Strong Buy | $80.00 | -7.32% | Upgrades | 9 months ago |
Crinetics Pharmaceuticals IncCRNX | 4 | Strong Buy | $52.00 | -37.75% | Maintains | 9 months ago |
Alkermes PLCALKS | 7 | Hold | $35.00 | -36.62% | Maintains | 10 months ago |
United Therapeutics CorpUTHR | 9 | Strong Buy | $330.00 | -41.46% | Maintains | a year ago |
Biocryst Pharmaceuticals IncBCRX | 3 | Strong Buy | $13.00 | N/A | Maintains | a year ago |
Immunocore Holdings PLCIMCR | 5 | Strong Buy | $50.00 | N/A | Maintains | a year ago |
Intra Cellular Therapies IncITCI | 6 | Strong Buy | $89.00 | N/A | Maintains | 2 years ago |
Mbx Biosciences IncMBX | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Deciphera Pharmaceuticals IncDCPH | 4 | Hold | $16.00 | N/A | Maintains | 2 years ago |
Cerevel Therapeutics Holdings IncCERE | 4 | Hold | $45.00 | N/A | Maintains | 3 years ago |
Karuna Therapeutics IncKRTX | 1 | Hold | $330.00 | N/A | Downgrades | 3 years ago |
Rayzebio IncRYZB | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Emergent Biosolutions IncEBS | 1 | Strong Sell | $9.00 | N/A | Downgrades | 3 years ago |
Esperion Therapeutics IncESPR | 5 | Hold | $9.00 | N/A | Maintains | 3 years ago |
Seagen IncSGEN | 2 | Strong Buy | $150.00 | N/A | Maintains | 3 years ago |
Tricida IncTCDAQ | 2 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Nektar TherapeuticsNKTR | 5 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Amarin Corp PLCAMRN | 4 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Tvardi Therapeutics IncTVRD | 2 | Strong Buy | $240.00 | N/A | Upgrades | 4 years ago |
Landos Biopharma IncLABP | 2 | Hold | $70.00 | N/A | Maintains | 5 years ago |
Dianthus Therapeutics IncDNTH | 1 | Hold | $7.00 | N/A | Downgrades | 5 years ago |
Lava Therapeutics NvLVTX | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 5 years ago |
Aptinyx IncAPTX | 1 | Strong Sell | N/A | N/A | Downgrades | 5 years ago |
Lexicon Pharmaceuticals IncLXRX | 1 | Hold | $7.00 | N/A | Upgrades | 5 years ago |
Stemline Therapeutics IncSTML | 2 | Strong Buy | $8.00 | N/A | Maintains | 6 years ago |
Arena Pharmaceuticals IncARNA | 1 | Strong Buy | $58.00 | N/A | Upgrades | 6 years ago |
Axcella Health IncAXLA | 2 | Strong Buy | $275.00 | N/A | Maintains | 7 years ago |
Aprea Therapeutics IncAPRE | 1 | Hold | $460.00 | N/A | Initiates Coverage On | 7 years ago |
Mersana Therapeutics IncMRSN | 3 | Strong Sell | N/A | N/A | Downgrades | 7 years ago |
Amag Pharmaceuticals IncAMAG | 1 | Strong Sell | $18.00 | N/A | Downgrades | 8 years ago |
Radius Health IncRDUS1 | 4 | Strong Buy | $52.00 | N/A | Maintains | 8 years ago |
Chimerix IncCMRX | 1 | Strong Sell | N/A | N/A | Downgrades | 8 years ago |
Enanta Pharmaceuticals IncENTA | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Advanced Accelerator Applications SaAAAP1 | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.